Published in Lancet on February 07, 2004
The utilization of testing and counseling for HIV: a review of the social and behavioral evidence. Am J Public Health (2007) 5.50
Routine HIV testing in Botswana: a population-based study on attitudes, practices, and human rights concerns. PLoS Med (2006) 4.86
Integrating HIV screening into routine health care in resource-limited settings. Clin Infect Dis (2010) 1.70
Sociocultural and epidemiological aspects of HIV/AIDS in Mozambique. BMC Int Health Hum Rights (2010) 1.64
Is 'Opt-Out HIV Testing' a real option among pregnant women in rural districts in Kenya? BMC Public Health (2011) 1.29
Community views about routine HIV testing and antiretroviral treatment in Botswana: signs of progress from a cross sectional study. BMC Int Health Hum Rights (2007) 1.08
Home-based HIV counseling and testing: client experiences and perceptions in Eastern Uganda. BMC Public Health (2012) 1.04
The complexity of consent: women's experiences testing for HIV at an antenatal clinic in Durban, South Africa. AIDS Care (2010) 1.02
Exploring synergies between human rights and public health ethics: A whole greater than the sum of its parts. BMC Int Health Hum Rights (2008) 0.90
Implementation and Operational Research: The Effectiveness of Routine Opt-Out HIV Testing for Children in Harare, Zimbabwe. J Acquir Immune Defic Syndr (2016) 0.87
HIV testing for pregnant women: a rights-based analysis of national policies. Glob Public Health (2012) 0.83
Costing human rights and community support interventions as a part of universal access to HIV treatment and care in a Southern African setting. Curr HIV Res (2011) 0.82
Provider-Initiated HIV Testing for Migrants in Spain: A Qualitative Study with Health Care Workers and Foreign-Born Sexual Minorities. PLoS One (2016) 0.80
Ethical issues surrounding the provider initiated opt--Out prenatal HIV screening practice in Sub-Saharan Africa: a literature review. BMC Med Ethics (2015) 0.75
A serostatus-based approach to HIV/AIDS prevention and care in Africa. Lancet (2003) 3.77
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med (2003) 28.68
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med (2004) 24.47
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med (2003) 10.39
Quality indicators for colonoscopy. Am J Gastroenterol (2006) 6.51
Medical sequencing at the extremes of human body mass. Am J Hum Genet (2007) 5.61
Incidence and prognosis of intraabdominal hypertension in a mixed population of critically ill patients: a multiple-center epidemiological study. Crit Care Med (2005) 4.61
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med (2004) 4.56
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry (2004) 4.46
Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. J Clin Invest (2003) 4.42
Quality indicators for colonoscopy. Gastrointest Endosc (2014) 4.17
The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med (2005) 4.07
Abstinence and abstinence-only education: a review of U.S. policies and programs. J Adolesc Health (2006) 4.01
Quality indicators for colonoscopy. Gastrointest Endosc (2006) 3.83
The tight calorie control study (TICACOS): a prospective, randomized, controlled pilot study of nutritional support in critically ill patients. Intensive Care Med (2011) 3.79
Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation. J Dev Behav Pediatr (2006) 2.73
Prevalence of intra-abdominal hypertension in critically ill patients: a multicentre epidemiological study. Intensive Care Med (2004) 2.56
Feasibility and acceptability of rapid HIV testing in jail. AIDS Patient Care STDS (2007) 2.52
The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on real-time endoscopic assessment of the histology of diminutive colorectal polyps. Gastrointest Endosc (2011) 2.51
For the law, neuroscience changes nothing and everything. Philos Trans R Soc Lond B Biol Sci (2004) 2.46
Violence, condom negotiation, and HIV/STI risk among sex workers. JAMA (2010) 2.45
Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis (2004) 2.17
Sepsis: time to reconsider the concept. Crit Care Med (2008) 2.17
People who use drugs, HIV, and human rights. Lancet (2010) 2.09
Quality indicators for colonoscopy. Am J Gastroenterol (2014) 2.06
Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med (2006) 2.04
A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock (2005) 1.97
Training with the compactEASIE biologic endoscopy simulator significantly improves hemostatic technical skill of gastroenterology fellows: a randomized controlled comparison with clinical endoscopy training alone. Gastrointest Endosc (2005) 1.96
Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes. J Infect Dis (2005) 1.91
A systematic review of population screening for fragile X syndrome. Genet Med (2010) 1.87
Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative. Biol Psychiatry (2008) 1.81
Access to pain treatment as a human right. BMC Med (2010) 1.70
Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation. J Antimicrob Chemother (2006) 1.70
Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH: a clinical and molecular genetic analysis. Lancet (2002) 1.69
Multisociety guideline on reprocessing flexible gastrointestinal endoscopes: 2011. Gastrointest Endosc (2011) 1.69
Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective. Intensive Care Med (2008) 1.57
Application of a rat model of streptococcal shock to evaluate on-line hemoperfusion and removal of circulating superantigens. Crit Care Med (2003) 1.51
Computerized energy balance and complications in critically ill patients: an observational study. Clin Nutr (2006) 1.50
Quality indicators for endoscopic retrograde cholangiopancreatography. Gastrointest Endosc (2006) 1.46
Addressing the educational void during the antiretroviral therapy rollout. AIDS (2004) 1.45
HIV testing experiences among male and female inmates in Rhode Island. AIDS Read (2007) 1.45
Preemptive enteral nutrition enriched with eicosapentaenoic acid, gamma-linolenic acid and antioxidants in severe multiple trauma: a prospective, randomized, double-blind study. Intensive Care Med (2015) 1.45
Reason and rights in global drug control policy. CMAJ (2005) 1.44
Comparison of metabolic monitors in critically ill, ventilated patients. Nutrition (2006) 1.44
Quality indicators for gastrointestinal endoscopic procedures: an introduction. Gastrointest Endosc (2006) 1.42
Quality indicators for endoscopic retrograde cholangiopancreatography. Am J Gastroenterol (2006) 1.42
Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: the GEMS Study. Atherosclerosis (2007) 1.36
Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Am J Cardiol (2005) 1.32
ERCP core curriculum. Gastrointest Endosc (2006) 1.30
Quality indicators for gastrointestinal endoscopic procedures: an introduction. Am J Gastroenterol (2006) 1.30
Sepsis biomarkers in unselected patients on admission to intensive or high-dependency care. Crit Care (2013) 1.29
Zosyn (piperacillin/tazobactam) reformulation: Expanded compatibility and coadministration with lactated Ringer's solutions and selected aminoglycosides. Ther Clin Risk Manag (2008) 1.27
The less they know, the better: abstinence-only HIV/AIDS programs in Uganda. Reprod Health Matters (2006) 1.25
Production of granulocyte colony-stimulating factor in the nonspecific acute phase response enhances host resistance to bacterial infection. J Immunol (2002) 1.25
The bacterial superantigen streptococcal mitogenic exotoxin Z is the major immunoactive agent of Streptococcus pyogenes. J Immunol (2002) 1.24
Health benefits of legal services for criminalized populations: the case of people who use drugs, sex workers and sexual and gender minorities. J Law Med Ethics (2010) 1.18
Quality indicators common to all GI endoscopic procedures. Gastrointest Endosc (2014) 1.17
AIDS in Uganda: the human-rights dimension. Lancet (2005) 1.17
Excellence in endoscopy: toward practical metrics. Gastrointest Endosc (2006) 1.15
Predictors of stress in mothers and fathers of children with fragile X syndrome. Res Dev Disabil (2005) 1.13
Scaling up HIV testing: human rights and hidden costs. HIV AIDS Policy Law Rev (2006) 1.12
Human rights and HIV prevention, treatment, and care for people who inject drugs: key principles and research needs. J Acquir Immune Defic Syndr (2010) 1.12
Lives to save: PEPFAR, HIV, and injecting drug use in Africa. Lancet (2009) 1.11
Infection with conditionally virulent Streptococcus pneumoniae Δpab strains induces antibody to conserved protein antigens but does not protect against systemic infection with heterologous strains. Infect Immun (2011) 1.10
Readmission to the intensive care unit after "fast-track" cardiac surgery: risk factors and outcomes. Ann Thorac Surg (2003) 1.09
The Neo-Papilla: a new modification of porcine ex vivo simulators for ERCP training (with videos). Gastrointest Endosc (2006) 1.07
Quality indicators for esophagogastroduodenoscopy. Am J Gastroenterol (2006) 1.06
Experiences with policing among people who inject drugs in Bangkok, Thailand: a qualitative study. PLoS Med (2013) 1.04
Changes in regional distribution of lung sounds as a function of positive end-expiratory pressure. Crit Care (2009) 1.04
Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet (2009) 1.04
Monetary benefits of preventing childhood lead poisoning with lead-safe window replacement. Environ Res (2007) 1.03
Guidelines for safety in the gastrointestinal endoscopy unit. Gastrointest Endosc (2014) 1.03
Family history is a major determinant of subclinical peripheral arterial disease in young adults. J Vasc Surg (2004) 1.02
Efficacy and costs of a one-day hands-on EASIE endoscopy simulator train-the-trainer workshop. Gastrointest Endosc (2005) 1.00
A model for offering carrier screening for fragile X syndrome to nonpregnant women: results from a pilot study. Genet Med (2008) 1.00
HLA class II polymorphisms determine responses to bacterial superantigens. J Immunol (2004) 0.98
Radical prostatectomy: pathology findings in 1001 cases compared with other major series and over time. BJU Int (2005) 0.97
Occupational safety and HIV risk among female sex workers in China: a mixed-methods analysis of sex-work harms and mommies. Glob Public Health (2012) 0.97
Neurobehavioural evidence for the involvement of the FMR1 gene in female carriers of fragile X syndrome. Neurosci Biobehav Rev (2013) 0.95
Reports of police beating and associated harms among people who inject drugs in Bangkok, Thailand: a serial cross-sectional study. BMC Public Health (2013) 0.95
Increased susceptibility of C1q-deficient mice to Salmonella enterica serovar Typhimurium infection. Infect Immun (2002) 0.95
Quality indicators for endoscopic ultrasonography. Am J Gastroenterol (2006) 0.94
Quality indicators for endoscopic ultrasonography. Gastrointest Endosc (2006) 0.94
Multisociety guideline on reprocessing flexible GI endoscopes: 2011. Infect Control Hosp Epidemiol (2011) 0.92
Harm reduction, HIV/AIDS, and the human rights challenge to global drug control policy. Health Hum Rights (2005) 0.92
Successful treatment of Bouveret syndrome using holmium: YAG laser lithotripsy. Am Surg (2005) 0.92
Quality indicators for EGD. Gastrointest Endosc (2014) 0.92
Quality indicators for ERCP. Gastrointest Endosc (2014) 0.92
Increasing access to HIV testing and counselling while respecting human rights. HIV AIDS Policy Law Rev (2007) 0.91
Tracking the microbes in sepsis: advancements in treatment bring challenges for microbial epidemiology. Clin Infect Dis (2007) 0.91
Preservation and Incorporation of Valuable Endoscopic Innovations (PIVI) on the use of endoscopy simulators for training and assessing skill. Gastrointest Endosc (2012) 0.90
Quality indicators for EUS. Gastrointest Endosc (2014) 0.90
Functional manipulations of acetylcholinesterase splice variants highlight alternative splicing contributions to murine neocortical development. Cereb Cortex (2005) 0.88
Ten reasons to oppose the criminalization of HIV exposure or transmission. Reprod Health Matters (2009) 0.88
"It's something I need to consider": decisions about carrier screening for fragile X syndrome in a population of non-pregnant women. Am J Med Genet A (2009) 0.88
Endoscopic treatment compared with medical therapy for the prevention of recurrent ulcer hemorrhage in patients with adherent clots. Gastrointest Endosc (2003) 0.88
Quality indicators for EGD. Am J Gastroenterol (2014) 0.87
"It's about having the choice": stakeholder perceptions of population-based genetic carrier screening for fragile X syndrome. Am J Med Genet A (2012) 0.87
Use of corticocancellous allogeneic bone blocks for augmentation of alveolar bone defects. Int J Oral Maxillofac Implants (2010) 0.87
Expression of lymphotoxin-beta (LT-beta) in chronic inflammatory conditions. J Pathol (2003) 0.87